Products in global plaquenil drugs market, Hydroxychloroquine, also known by the brand name of plaquenil, is an anti-rheumatic drug that modifies the disease in the body. It helps protect against the joint damage while easing the swelling and pain caused by arthritis. Prevalence of life threatening diseases such as corona virus and malaria have led to an increased demand in global plaquenil drugs market. Increasing concerns regarding risks of various autoimmune and infectious diseases has also contributed to the growing global plaquenil drugs market. On the other hand, various severe side effects caused by the plaquenil drug can impede the growth of the global plaquenil drugs market in coming years. These side effects include feeling sick, headaches, visual problems, damaging the internal part of human retina, skin rashes, diarrhea, and hair loss. Some of these side effects can prove to be long lasting or even permanent. This can affect the growth of global plaquenil drugs market in a negative way in near future.
Get Sample Copy of this Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=7335
Asia Pacific Plaquenil Drugs Market Expected to Witness Robust Growth in Near Future
Some of the key vendors in global plaquenil drugs market are Cadila Healthcare Ltd, Ipca Laboratories Ltd, Novartis AG, Sanofi S. A., Teva Pharmaceuticals Industries, Zydus Cadila, Mylan N. V., and Pfizer Inc. Players in global plaquenil drugs market are focusing on expanding their product portfolio to meet the demand from diverse set of industries such as pharmaceutical, biomedical, animal healthcare and engaging in strategies to expand their consumer base and regional presence. For example, Cadila Healthcare Ltd internally restructured their firm and announced that they acquired approval for transferring their animal health care business to their independently owned firm ‘Zydus Animal Health and Investments Ltd.’ in March of 2020.
Rising geriatric population, high rate of new cases of arthritis, malaria, and corona virus, and rising demand for effective medication are some of the key factors responsible for the robust growth of Asia Pacific plaquenil drugs market in coming years. Presence of leading vendors in countries such as India and China is also another huge motivator for the global drugs plaquenil market in Asia Pacific region.
Check Table of Contents of this Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=7335